The meeting between Gpi and Umana Medical Technologies, a Maltese start-up founded in 2017, has transformed over time into a profitable synergy until, after a year of collaboration, it reached the choice of transforming the partnership into a “venture”.
Gpi has now acquired control of Umana with the aim of combining the skills, vision and strengths to innovate the social-welfare models.
Umana Medical Technologies develops innovative solutions for socio-health monitoring, such as nanomaterial tattoo sensors, i.e. sensors / tattoos based on nanotechnologies, a patch easily applicable to the human body that detects the person’s vital parameters and transmits them to the Umana T1 cardiac monitor.
Press review
Business Weekly, 21 May 2020
Sunday Times Malta, 25 May 2020
A scientific study has been published on an innovative AI system for early skin cancer detection.
STRATEGIC HORIZONS: Gpi’s Industrial Plan 2025 – 2029
A new scientific publication delves into the Gpi case and the challenges of sustainable digital transformation.
